Announcements
- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
- Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
More ▼
Key statistics
On Friday, Enzo Biochem Inc (EZB:FRA) closed at 0.955, 0.00% above its 52-week low of 0.955, set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.955 |
---|---|
High | 0.955 |
Low | 0.955 |
Bid | 0.945 |
Offer | 0.99 |
Previous close | 0.96 |
Average volume | 0.00 |
---|---|
Shares outstanding | 51.23m |
Free float | 38.83m |
P/E (TTM) | -- |
Market cap | 53.27m USD |
EPS (TTM) | -0.4699 USD |
Data delayed at least 15 minutes, as of May 03 2024 07:15 BST.
More ▼